Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Does the presence of an SVC stent preclude 60/40 or other BID dose escalation for SCLC?
Answer from: Radiation Oncologist at Community Practice
There is no evidence to guide the practice one way or the other. From a biological standard point, it should not.
Sign In
or
Register
to read more
30024
Related Questions
Does receipt of chemoimmunotherapy for LS-SCLC impact your recommendation for PCI?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?
Is there a concern for using FFF beams in single isocenter multi target lung SBRT?
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
Is there a role for focal radiation in peritoneal mesothelioma following cytoreductive surgery/ HIPEC?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
How does neoadjuvant chemo-immunotherapy impact your decision on hypofractionation/dose fractionation for locally advanced NSCLC, now getting RT alone?
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?